Body mass index (BMI) as a prelude to hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH) risk factors in patients with no identified risk factor for developing hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Al Mahmasani, L.; Capanu, M.; Srivastava, A.; Chou, J. F.; Shia, J.; El Dika, I. H.; Yaqubie, A.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.
Abstract Title: Body mass index (BMI) as a prelude to hepatocellular carcinoma (HCC) and metabolic dysfunction-associated steatohepatitis (MASH) risk factors in patients with no identified risk factor for developing hepatocellular carcinoma (HCC)
Meeting Title: 2024 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 16 Suppl.
Meeting Dates: 2024 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001275557404297
PROVIDER: wos
DOI: 10.1200/JCO.2024.42.16_suppl.e16193
Notes: Meeting Abstract: e16193 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    331 Chou
  2. James Joseph Harding
    250 Harding
  3. Ghassan Abou-Alfa
    568 Abou-Alfa
  4. Marinela Capanu
    385 Capanu
  5. Jinru Shia
    715 Shia
  6. Eileen O'Reilly
    780 O'Reilly
  7. Amin Taher Yaqubie
    23 Yaqubie
  8. Imane El Dika
    65 El Dika